What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
.
Methods Mol Biol. 2007;379:51-68. doi: 10.1007/978-1-59745-393-6_4. Methods Mol Biol. 2007. PMID: 17502670 Free PMC article.
.